A carregar...

Tumor cell–intrinsic USP22 suppresses antitumor immunity in pancreatic cancer

Although immune checkpoint blockade (ICB) improves clinical outcome in several types of malignancies, pancreatic ductal adenocarcinoma (PDA) remains refractory to this therapy. Preclinical studies have demonstrated that the relative abundance of suppressive myeloid cells vs. cytotoxic T cells determ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Res
Main Authors: Li, Jinyang, Yuan, Salina, Norgard, Robert J, Yan, Fangxue, Yamazoe, Taiji, Blanco, Andrés, Stanger, Ben Z.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7173406/
https://ncbi.nlm.nih.gov/pubmed/31871120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-19-0661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!